JOSHUA MORRIS: Open Payments
NPI 1215224902 · BRISTOL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 87 payments from 11 companies in 2025. Trend: 2023 $669 · 2024 $636 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $315 |
| Vanda Pharmaceuticals Inc. | 11 | $181 |
| Indivior Inc. | 5 | $144 |
| Braeburn Inc. | 18 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $83 |
| Novo Nordisk Inc | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Gilead Sciences, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Inspire Medical Systems, Inc. | 1 | $31 |
Products named: VRAYLAR, SUBLOCADE, BRIXADI, HETLIOZ, MAVYRET, CAPLYTA, FANAPT, REXULTI.
Industry payments across VA — which companies pay providers there.
